Background and Aim: Reddish depressed lesions (RDLs) frequently observed in patients following Helicobacter pylori eradication are indistinguishable from gastric cancer. We examined the clinical and histological feature of RDLs and its relevant endoscopic diagnosis including magnifying narrow-band imaging (M-NBI). Methods: We enrolled 301 consecutive patients with H. pylori eradication who underwent endoscopy using white light imaging (WLI). We examined the prevalence and host factors contributing to the presence of RDLs. Next, we used M-NBI in 90 patients (104 RDLs), and compared the diagnostic efficacy between M-NBI and WLI groups using propensity-score matching analysis. Results: In 301 patients after eradication, 117 (39%) showed RDLs. Male, open-type atrophy, and gastric cancer history were risk factors for RDLs. A gastric biopsy was needed in 83 (71%) during WLI observation and only 2 were diagnosed with adenocarcinoma. In M-NBI group, a biopsy was performed in 21 (20%), and 9 were diagnosed with adenocarcinoma. A biopsy was required in fewer patients, and the positive predictive value of a biopsy was statistically higher in M-NBI than in the WLI group (p < 0.01). Conclusions: RDLs are frequently observed in high-risk patients for gastric cancer after eradication. M-NBI demonstrated significantly superior diagnostic efficacy with respect to RDL.
Introduction
Helicobacter pylori infection is strongly associated with the incidence of gastric cancer [1] . H. pylori infection causes chronic atrophic gastritis followed by the development of gastric neoplasia. A prospective study in Japan has shown that H. pylori eradication therapy following endoscopic resection of early gastric cancer reduces the incidence of metachronous gastric cancer [2] . In 2013, the Japanese national health insurance system achieved the distinction of being the first in the global context to cover H. pylori eradication therapy for chronic gastritis. Therefore, an increasing number of Japanese patients are receiving eradication therapy aimed at prevention of gastric cancer.
However, it has been observed that some patients with atrophic gastritis developed clinically diagnosed gastric cancer even after successful eradication therapy [3, 4] . Gastric cancer detected after successful eradication therapy (GCAE) endoscopically appears predominantly as a flat depression [5, 6] . Our previous study described posteradication morphological alterations in early gastric cancer, which appeared as flattening of an elevated-type cancer [7] . This finding supports the fact that in patients with gastric cancer detected after eradication, the macroscopic morphology is predominantly a flat depressedtype lesion.
Based on the recently proposed Kyoto classification system for the diagnosis of H. pylori-associated gastritis, patchy redness and/or map-like redness are considered representative endoscopic features in lesions observed after successful eradication [8] . Nagata et al. [9] reported that endoscopic findings of mottled patchy erythema were characteristic of pathological intestinal metaplasia in patients who have received eradication therapy. In addition, Moribata et al. [10] report that the presence of map-like redness observed after H. pylori eradication is a useful endoscopic marker to predict a diagnosis of metachronous gastric cancer following endoscopic submucosal dissection [10] . Kitamura also reported that gastric xanthoma may be a useful predictive marker for the development of gastric cancer detected after eradication therapy [11] .
Clinical endoscopic examination often reveals multiple reddish depressed lesions (RDLs) in patients administered eradication therapy. However, gastric cancer lesions might also present as RDLs and are often indistinguishable from non-neoplastic RDLs with similar features. In the present study, we focused on RDLs in patients who had undergone successful eradication therapy and attempted to determine the clinical and histopathological findings associated with these lesions. Moreover, we also investigated the diagnostic efficacy of endoscopy, including the use of magnifying narrowband imaging (M-NBI) with regard to RDLs. Furthermore, we assessed the clinical significance of these lesions in terms of their malignant/premalignant potential.
Patients and Methods

Definition of RDLs Observed Using Endoscopic Examination
In the present study, we defined RDLs as lesions: (1) showing clear redness compared to the surrounding mucosa using white light imaging (WLI), (2) identified as well-localized areas, (3) showing definite depression, and (4) measuring ≤20 mm in diameter. Endoscopic features were primarily diagnosed using the Kyoto classification system [8] . Some reddish lesions could be recognized as map-like redness or patchy redness defined in Kyoto classification [8] . If the reddish lesion met our criteria, we judged the lesion as RDL. Atrophic gastritis in the corpus was classified based on the Kimura-Takemoto classification [12] .
Use of WLI to Diagnose RDLs in Patients Presenting after Successful Eradication Therapy
We registered 301 consecutive patients (211 men, median age 60.6 years) who presented at the Hiroshima University Hospital or Kawamura Clinic (Hiroshima, Japan) after successful eradication therapy and underwent endoscopic examination between April 2014 and May 2015 using WLI for cancer screening. We examined the incidence of RDLs in these patients. NBI was not used for gastric cancer screening during the endoscopic examination. Successful eradication was confirmed using a urea breath test (Otsuka, Japan) with the cut-off level being set at 2.5‰. Endoscopic findings and clinical characteristics were recorded and were subsequently analyzed. We also enrolled another group of 301 patients as controls (198 men, median age 63.5 years) who had not received eradication therapy and underwent endoscopic examination during the same period (176 patients showed no atrophy [C0/1] and 125 showed atrophy [C1<]).
Based on reports described by Yao et al. [13] , a gastric biopsy was performed in patients in whom we identified an irregularity (heterogeneous color, irregular demarcation or spiny depressed lesion) in RDLs. We investigated the prevalence of gastric cancer using histopathological examination of biopsy specimens in these RDLs. In patients with multiple RDL by WLI, we evaluated and registered the most suspicious RDL.
Observation Using M-NBI for Endoscopic Diagnosis of RDLs
Next, as a follow-up study, we enrolled 90 consecutive patients (67 men, median age 64 years) who presented after successful eradication showing 104 RDL lesions. These patients underwent endoscopic examination using M-NBI for gastric cancer screening between June 2015 and January 2017. Based on the vessel plus surface classification system, we performed a gastric biopsy when the RDLs revealed an irregular microvascular pattern and/or irregular microsurface pattern within the demarcation line [14] . Based on the classification reported by Kawamura et al. [15] with some modification, we categorized a non-neoplastic pattern of RDLs into regular round or non-round. NBI pattern was judged by the endoscopist at first, and subsequently checked at the meeting. By using NBI images, 2 experts (T.K. and Y.S.) independently evaluated the NBI pattern to access the kappa value of inter-observer agreement for diagnose of NBI pattern in RDLs.
We used a magnifying video-endoscope and an electronic endoscopic system (GIF-H260Z, GIF-H290Z and EVIS LUCERA SPECTRUM, ELITE, Olympus Medical Systems, Tokyo, Japan) with the following settings: A-mode level 7 for WLI, B-mode level 8 for NBI, and level 1 for color enhancement.
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In both WLI and M-NBId studies, 7 experts (T.K., M.I., T.B., M.K., K.M., K.H., and T.K.) carried out each endoscopic examination. Furthermore, after examination, each endoscopic diagnosis was double-checked by other experts. This study was conducted as a retrospective study. The Ethics Committee of Hiroshima University Hospital approved our study (E-710).
Statistical Analysis
Categorical data were compared using the χ 2 test and the Fisher exact test, and numerical data were analyzed using the Wilcoxon rank sum test. A p value <0.05 was considered statistically significant. JMP statistical software (SAS Institute Inc., Cary, NC, USA) was used for all calculations. Univariate and multivariate logistic regression analyses were performed to assess the clinical characteristics of patients with and without RDLs. Confidence intervals were computed with normal approximation of the binomial distribution. We used propensity-score matching analysis to compare the diagnostic efficacy of WLI versus M-NBI with respect to RDLs. Variables included to calculate the propensity score were age, sex, grade of atrophy, and history of endoscopic resection for previous gastric cancer. After propensity scores were estimated, one-to-one nearest-neighbor matching without replacement was performed with a caliper of width equal to 0.2 of the standard deviation of the logit of the propensity score [16] .
Results
Prevalence of RDLs in Subjects with Eradication Therapy
We examined the prevalence of RDLs in 301 consecutive patients who presented after successful eradication therapy and underwent endoscopic examination for gastric cancer screening. In these 301 patients after eradication, RDLs were detected in 117 patients either in the corpus or in the antrum, and the prevalence was statistically higher than that in non-eradicated controls with or without atrophic gastritis in the corpus (Table 1) . Of the 117 patients detected using WLI, multiple RDLs were found in 92 (79%) patients. We concluded that 83 lesions (71%) needed histopathological evaluation by obtaining biopsy specimens based on the criteria recommended by Yao et al. [13] . Only 2 lesions (1.7%) were diagnosed as gastric adenocarcinoma following a histopathological examination (Fig. 1) .
Host Factors Contributing to the Appearance of RDLs
We further examined the host factors contributing to the appearance of RDLs in the gastric mucosa after eradication therapy. 
Endoscopic Appearance of RDLs Using M-NBI and Their Corresponding Histopathological Features
On receiving the results from first study with WLI, we examined the diagnostic efficacy of M-NBI by comparing it with conventional endoscopy. We used M-NBI in 90 consecutive patients with 104 RDLs who presented after successful eradication therapy. We observed an irregular pattern that necessitated biopsy in 21 (20%) lesions (Fig. 2) . The kappa value of inter-observer agreement in 2 expert endoscopists (T.K. and Y.S.) was 0.7. Of these 21 lesions, 9 (43%) were histopathologically diagnosed as being adenocarcinomas (Fig. 2) . Vascular irregularity was noted in all 9 lesions, whereas a regular microstructural pattern was observed in 2 lesions. The remaining 83 (20 round and 63 non-round lesions) were considered to have a regular pattern. Representative histopathological features have been demonstrated in Figure 3 . In RDLs showing a regular round pattern, histopathological examination showed preserved fundic glands. Additionally, in RDLs showing a non-round pattern, we observed small regenerative glands with intestinal metaplasia and lymphocytic infiltration. 
Comparison between the Diagnostic Efficacy of M-NBI and WLI
We examined the difference between the diagnostic efficacy of endoscopic examination using WLI and M-NBI (Table 3 ). There was no statistically significant difference between the groups in terms of the clinical background of patients with regard to gastric cancer risk (sex, age, grade of atrophy, and history of gastric cancer). Gastric cancer was diagnosed in 2 (1.7%) and 9 (8.7%) patients in the WLI and M-NBI groups respectively. The prevalence of a gastric biopsy was statistically lower (20 vs. 71%, p < 0.01); however, the positive predictive value (PPV) of a biopsy was statistically higher (43 vs. 2.4%, p < 0.01) in the M-NBI group than in the WLI group. After propensity-score matching, 78 lesions were selected in each group. In M-NBI group, lower prevalence of taking gastric biopsy and higher PPV of biopsy was also confirmed (p < 0.01).
Discussion
The widespread use of H. pylori eradication therapy highlights the need for accurate diagnosis and treatment of GCAE. As reported previously, using conventional endoscopic examination, GCAE presents as small RDLs [6, 17] , which are often indistinguishable from those that are noted in the background mucosa after successful eradica- tion therapy. Thus, GCAE is difficult to diagnose in some patients. The PPV of a conventional endoscopic biopsy examination using WLI was observed to be only 2.4% (2/83) in patients who received eradication therapy, which is not superior to the PPV reported in those without eradication therapy [18] . We observed that the presence of RDLs was correlated with the male gender, corpus atrophy, and history of gastric cancer. These factors are closely related to the development of gastric cancer following eradication therapy [19, 20] . These findings suggest that at least a few RDLs may be associated with a malignant potential even if they have not been definitively diagnosed as malignant. Maplike redness, which is generally larger than RDL, is also typical endoscopic finding in patients after successful eradication therapy. However, in the clinical practice, the majority of GCAE were detected as small RDL-like features, and were not similar to map-like redness. Therefore, in the present study, we defined the RDL as being less than 20 mm. In addition, in Kyoto classification system, there is no clear definition concerning reddish lesion such as map-like redness or patchy redness. For accurate diagnosis, clear definition of reddish lesion including RDL should be added in Kyoto classification. Clinically, we have to pay attention to localized reddish lesion with depression before using M-NBI, and these endoscopic features require close attention and careful follow-up, particularly during cancer screening. Nagata et al. [9] have demonstrated that mottled patch erythema, which may include RDLs, is a response to intestinal metaplasia. In the present study, we demonstrated that a variety of magnifying patterns were found in association with RDLs, and the histopathological features of RDLs were not identical. For example, we confirmed a non-atrophic fundic gland in lesions with a round pattern. Intestinal metaplasia with regenerative changes was observed in lesions with a non-round pattern, which was noted to be a dominant group among all RDLs.
Magnifying endoscopic observation is a new tool to aid in the accurate diagnosis of gastric neoplasms with recent reports describing high accuracy and diagnostic efficacy in detecting early gastric cancer [21, 22] . However, it is uncertain whether M-NBI is effective in diagnosing GCAE because of its characteristic endoscopic or histopathological features. We previously reported that mature (non-neoplastic or well-developed) epithelium appeared on the surface of gastric cancer after successful eradication therapy [7] . Recently we reported that the same epithelium (referred to as epithelium with lowgrade atypia) was also detected in gastric cancer tissue detected after successful eradication therapy [23] . Saka et al. [24] and Hori et al. [25] have reported the same histological morphology in their studies.
Ours is the first study to demonstrate the high diagnostic efficacy of M-NBI in those presenting with GCAE. Notably, the PPV of a gastric biopsy was significantly high using M-NBI, although only a few patients needed a gastric biopsy. It is recommended that endoscopic examination for patients who have undergone eradication therapy must involve initial detection of RDLs using WLI followed by the use of M-NBI to accurately diagnose the RDL. M-NBI may be particularly useful to diagnose multiple RDLs detected using WLI.
Kobayashi et al. [26] have described a "gastritis-like appearance" of these lesions using M-NBI, which makes it difficult to diagnose GCAE. To detect GCAE, the vascular pattern seems to be more important than the structural pattern, which may be because of the characteristic histopathological alterations in the surface of gastric cancer lesions [7] . Mechanical settings may be important because a processer set to a B-mode level 8 for NBI and level 1 for color enhancement best demonstrates the microvascular pattern. Additionally, surface irregularity of lesions was also detected in most cases suggesting a partial influence of epithelium with low-grade atypia on the surface of GCAE lesions. A false-negative diagnosis of GCAE is possible in cases, wherein the surface irregularity is completely masked.
A limitation of this study is the relatively small number of patients who underwent M-NBI evaluation and were diagnosed as having an irregular pattern of lesions. After propensity-score matching, we could demonstrate the superior PPV of a gastric biopsy although a biopsy was performed in only a few patients; however, we could not confirm a statistically significant difference in the gastric cancer detection rate between the groups. In addition, since we investigated the rate of biopsy in the endoscopic examinations, we could evaluate the diagnostic ability of WLI and M-NBI for gastric cancer in RDLs only by PPV; which is another limitation of this study. Further prospective studies may be needed to confirm the efficacy of M-NBI for a cancer survey because M-NBI needs a longer time and may inflict pain on some patients.
In conclusion, we assessed the clinical importance and malignant potential of RDLs presenting after successful eradication therapy. Further research is warranted to perform detailed molecular analysis to accurately determine the biological status of these lesions, which would help to reduce mortality rates in patients with gastric cancer presenting with RDLs after successful eradication therapy.
